Recent years have seen a significant shift towards the adoption of open-source software like R by statisticians and analysts in both industry and regulatory agencies. This trend offers immense benefits, including cutting-edge statistical tools, …
In this talk, we would like to provide updates on the four biopharmaceutical industry focused R consortium cross-industry working groups. These working groups have a similar overall objective to support the use of R within the biopharmaceutical …